JHP Pharmaceuticals

What JHP Pharmaceuticals does

JHP Pharmaceuticals (also operating as MCP Pharmaceuticals and My Canadian Pharmacy) is a US-based, privately held specialty pharmaceutical and contract development and manufacturing organization (CDMO) headquartered in Parsippany, New Jersey, with primary manufacturing operations in Rochester, Michigan and a Canadian operations support office in Edmonton. The company is built around an integrated sterile injectable platform spanning aseptic fill & finish, lyophilization, and biologics production, supported by cGMP compliance certified by the FDA (CDER and CBER), EMEA, and ANVISA. Its revenue is generated through three distinct streams: (1) contract manufacturing services for global pharmaceutical and biotech companies, covering clinical and commercial supply of sterile injectables, biologics, vaccines, and lyophilized products, with supporting regulatory, analytical methods, package engineering, stability testing, and validation services typically structured as multi-year negotiated agreements; (2) branded aseptic injectable pharmaceuticals sold directly to hospitals and clinical settings, including Adrenalin, Coly-Mycin M, Pitocin, Dantrium IV, and the Aplisol TB diagnostic; and (3) a direct-to-consumer online pharmacy channel (My Canadian Pharmacy) selling generic medications including erectile dysfunction, antibiotic, antiparasitic, and hormone therapy products, with home delivery to over 80 countries.

The company's competitive position rests on more than 25 years of sterile manufacturing experience at its Rochester facility, a claimed 100+ years of combined biologics and vaccines expertise, and use of disposable product contact equipment that reduces manufacturing cycle times. JHP is owned by private equity firm Warburg Pincus, which acquired the company in December 2012, and has since invested in capacity expansion, including a new $10 million, 40,000 sq. ft. laboratory for QC Chemistry, Method Transfer, Sterility Assurance and Stability. Products manufactured or distributed by JHP reach 86 countries globally.

Name

JHP Pharmaceuticals

Legal name

MCP Pharmaceuticals LLP

Website

http://www.jhppharma.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

251–500 employees

Short description

JHP Pharmaceuticals is a US-based, PE-owned specialty pharma and sterile injectable CDMO (Rochester, MI) that performs aseptic fill & finish and lyophilization for global pharma clients, sells branded injectables (Adrenalin, Pitocin, Dantrium IV, Aplisol) to hospitals, and distributes generics via its My Canadian Pharmacy consumer channel.

Ownership category

akta.pro rank

Product category

Sterile Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Sterile injectable manufacturing
• Contract pharmaceutical manufacturing
• Aseptic fill finish
• Lyophilization services
• Branded injectable pharmaceuticals

Headquarters

HQ city

Parsippany

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Provides contract manufacturing services for global pharmaceutical companies, producing clinical and commercial supplies of sterile injectable products including biologics, vaccines, and drug products. Services include Regulatory, Analytical Methods Development, Package Engineering, Stability Testing and Validation.
2. Branded Pharmaceutical Products: Manufactures and sells branded aseptic injectable pharmaceuticals in hospital and clinical settings. Own product portfolio includes leading diagnostic, women's health and anesthesia products such as Adrenalin, Coly-Mycin M, Pitocin, Dantrium IV, and Aplisol (TB diagnostic).
3. Online Pharmacy/Retail: Operates My Canadian Pharmacy online platform selling generic pharmaceutical products directly to consumers, including erectile dysfunction medications, antibiotics, and other generic drugs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

JHP Pharmaceuticals is an integrated specialty pharmaceutical company that provides cGMP-compliant sterile injectable contract manufacturing services (aseptic fill & finish, lyophilization, biologics and vaccine production) to global pharmaceutical and biotech companies, while also manufacturing and selling its own branded injectable products (Adrenalin, Coly-Mycin M, Pitocin, Dantrium IV, Aplisol) and generic medications (Sildenafil, Tadalafil, Ivermectin, Amoxil) through hospital channels and an online pharmacy.

Product overview

JHP Pharmaceuticals (My Canadian Pharmacy/MCP Pharmaceuticals) is an integrated specialty healthcare company specializing in sterile injectable products. The company operates two divisions: (1) Contract Manufacturing Services providing cGMP-compliant clinical and commercial aseptic fill & finish, lyophilization, and validation services for global pharmaceutical and biotech companies; and (2) Branded/Generic Pharmaceuticals including diagnostic products (Aplisol for TB), women's health products (Pitocin, Estradiol Valerate), anesthesia products (Dantrium IV), and a portfolio of generic medications. The generic portfolio includes erectile dysfunction treatments (Sildenafil, Tadalafil, Avanafil, Dapoxetine), antiparasitics (Ivermectin), antibiotics (Colistimethate, Amoxil), and natural supplements (Yagara). MCP's Rochester, Michigan facility has over 25 years of experience and manufactures products for sale in 86 countries, shipping to over 80 countries globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services cGMP-compliant contract manufacturing for global pharmaceutical and biotech companies, producing clinical and commercial supplies of sterile injectable products including biologics, vaccines, and drug products in liquid, lyophilized and suspension presentations.
• Aplisol TB diagnostic product used for tuberculosis detection in clinical settings, with branded positioning for hospital and clinical use.
• Adrenalin Brand aseptic injectable pharmaceutical used in hospital and clinical settings, part of JHP's branded sterile injectable portfolio with new multipack presentations.
• Coly-Mycin M Brand aseptic injectable antibiotic pharmaceutical used in hospital and clinical settings, part of JHP's branded sterile injectable portfolio with new multipack presentations.
• Pitocin Brand aseptic injectable pharmaceutical used in women's health applications, part of JHP's branded sterile injectable portfolio with new multipack presentations.
• Dantrium IV FDA-approved sterile injectable product featuring rapid mixing capability in 20 seconds, used for muscle relaxation indications in hospital and clinical settings.
• Generic Pharmaceutical Portfolio (Sildenafil, Tadalafil, Ivermectin, Amoxil, Avanafil, Dapoxetine, Colistimethate, Estradiol Valerate) Generic pharmaceutical products sold via the My Canadian Pharmacy online storefront, including erectile dysfunction medications (Sildenafil/Viagra, Tadalafil/Cialis, Avanafil/Stendra, Dapoxetine/Priligy), antibiotics (Amoxil, Colistimethate), antiparasitics (Ivermectin/Stromectol), and hormone therapy (Estradiol Valerate), offered as affordable alternatives to brand drugs.
• Regulatory Services Comprehensive regulatory support included in contract manufacturing services, helping customers navigate global regulatory requirements including FDA, EMEA, and ANVISA frameworks.
• Analytical Methods Development Laboratory services for analytical method development supporting contract manufacturing customers, part of JHP's new laboratory facilities.
• Validation Services Validation services for manufacturing processes and equipment offered as part of the contract manufacturing suite for sterile injectable and biologic products.
• Technology Transfer and Method Transfer Services Technology transfer and method transfer services supporting customers as they progress from clinical batch production to commercialization at the Rochester facility.

Quantifiable outcome

• Products sold in 86 countries globally
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Undisclosed Biotechnology CompanycoreStrategic or Co-development Partner · 17 April 2013MCP entered into an agreement with a biotechnology company to produce clinical supplies of a biologic for late-phase clinical trials. MCP's cGMP compliance history and strategic use of disposable product contact equipment were key factors in selection.
• Putney Inc.coreStrategic or Co-development Partner · 27 January 2011MCP & Putney Inc. announced a multi-year contract manufacturing agreement for production of pharmaceutical products.
• SpePharmcoreStrategic or Co-development Partner · 20 August 2008MCP & SpePharm completed purchase of Dantrium (dantrolene sodium), expanding their pharmaceutical product portfolio.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Aurobindo Pharma: Vertically integrated pharmaceutical manufacturer with significant sterile injectable capabilities and broad generic portfolio. Comparable on injectable manufacturing scale, generic injectables, and global distribution footprint.
• Catalent: Major global CDMO with significant sterile injectable and biologics manufacturing capabilities serving pharma and biotech customers. Direct comparable as both companies provide cGMP-compliant contract manufacturing for sterile injectables and biologics.
• Hikma Pharmaceuticals: Specialty pharmaceutical company focused on sterile injectable generics and branded specialty products sold to hospitals. Directly comparable business model with branded injectables, generics, and contract manufacturing capabilities.
• Akorn: Specialty pharmaceutical company focused on sterile injectable and topical pharmaceutical products. Direct comparable in specialty injectables with hospital sales focus, though primarily branded rather than CDMO-focused.
• Cambrex: Specialty CDMO providing active pharmaceutical ingredient and finished dosage form manufacturing services including sterile injectables. Direct comparable in CDMO business model, though focused more on API and small molecules.
• Apotex: Canadian-headquartered generic pharmaceutical manufacturer with injectable capabilities and global distribution. Comparable on generic pharmaceutical manufacturing with focus on affordable medications, though less CDMO-focused.
• Lannett: Generic pharmaceutical manufacturer with focus on sterile injectable products and oral solid dosages. Comparable on injectable manufacturing capabilities and generic business, similar mid-sized scale and customer base.

Broad incumbents

• Patheon (Thermo Fisher Scientific): One of the largest CDMOs globally, offering sterile injectable manufacturing as part of a broader pharma services portfolio. Comparable on CDMO business model and customer base, though much larger and more diversified across dosage forms and services.
• Pfizer CentreOne: Pfizer's contract manufacturing arm offering sterile injectable CDMO services as part of a much larger global pharma company. Comparable CDMO offerings but operates at vastly larger scale as a non-core business of a major pharma.
• Viatris (Mylan): Global pharmaceutical company with significant sterile injectable, generic, and specialty pharmaceutical businesses. Comparable across multiple JHP business lines including sterile injectables and generics, though at vastly larger scale and broader geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/par-sterile-products

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JHP Pharmaceuticals